Neuroplast
Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
Total raised
€14M
€14,000,000
Funding rounds
2
Investors
4
distinct backers
Active since
2020-02
latest 2021-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood20
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 12y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-18 | Series B | €10M | Brightlands Venture Partners,Lumana Invest,Netherlands Enterprise Agency,NV Industriebank LIOF | View deal → |
| 2020-02-19 | Other | €4.0M | — | View deal → |
Investors
4Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech